Since the 23 differentially expressed genes were all expressed at lower levels in patients with MBP-induced T-cell proliferation, these results suggest an association between low endogenous type I IFN activity and T-cell reactivity to MBP in untreated MS patients. The gene discussed is MBP; the disease is myeloid sarcoma.